Key result
Novel hs-cTnI-EXL assay matches established troponin assays for MI diagnosis with ~99.5% NPV.
Why the study?
The clinical performance of the novel high-sensitivity cardiac troponin I EXL (hs-cTnI-EXL) assay for the early diagnosis of myocardial infarction was unknown.
Does the novel hs-cTnI-EXL assay and its 0/1h-algorithm provide comparable diagnostic accuracy for early diagnosis of myocardial infarction compared to hs-cTnI-Architect and hs-cTnT-Elecsys in patients presenting to the emergency department with symptoms suggestive of myocardial infarction?
Observational (n=1,454)
Yes
Does the novel hs-cTnI-EXL assay and its 0/1h-algorithm provide comparable diagnostic accuracy for early diagnosis of myocardial infarction compared to hs-cTnI-Architect and hs-cTnT-Elecsys in patients presenting to the emergency department with symptoms suggestive of myocardial infarction?
Answers are grounded in this paper and cite their sources.
The novel hs-cTnI-EXL assay and its derived 0/1h-algorithm demonstrate high diagnostic accuracy comparable to established hs-cTnI and hs-cTnT assays, allowing safe early rule-out and accurate rule-in of myocardial infarction in the emergency department.
Background The clinical performance of the novel high-sensitivity cardiac troponin I EXL (hs-cTnI-EXL) assay is unknown so far. Purpose We aimed to validate the clinical performance of the hs-cTnI-EXL assay and to derive and validate an hs-cTnI-EXL-specific 0/1h-algorithm for the early diagnosis of myocardial infarction (MI). Methods This multicenter study included patients presenting to the emergency department with symptoms suggestive of myocardial infarction. Central adjudication of final diagnoses was performed by two independent cardiologists using all clinical information including cardiac imaging twice: first, using serial hs-cTnI-Architect (primary analysis) and second, using serial hs-cTnT-Elecsys (secondary analysis) concentrations in addition to those clinically used (hs)-cTn. Hs-cTnI-EXL was measured at presentation and at 1h. The primary objective was to directly compare diagnostic accuracy quantified by the area under the receiver-operating-characteristic curve (AUC) of hs-cTnI-EXL, hs-cTnI-Architect and hs-cTnT-Elecsys. Secondary objectives included the derivation and validation of an hs-cTnI- EXL-specific 0/1h-algorithm. Results MI was the adjudicated final diagnosis in 204/1454 (14%) patients. At presentation, the AUC for hs-cTnI-EXL was 0.94 (95% CI, 0.93–0.96), being comparable to hs-cTnI-Architect (0.95; 95% CI, 0.93–0.96) and hs-cTnT-Elecsys (0.93; 95% CI, 0.91–0.95; Figure 1). In the derivation cohort (n=813), an optimal hs-cTnI-EXL-0/1h-algorithm was rule-out of MI with <9ng/L if onset of chest pain >3h or <9ng/L & 0h-1h-change <5ng/L, and rule-in with ≥160ng/L or 0h-1h-change ≥100ng/L. In the validation cohort (n=345), this hs-cTnI-EXL-0/1h-algorithm also performed well: rule-out in 56% of patients, negative predictive value 99.5% (95% CI, 97.1–99.9), sensitivity 97.8% (95% CI, 88.7–99.6), rule-in in 9% of patients, positive predictive value 83.3% (95% CI, 66.4–92.7), specificity 98.3% (95% CI, 96.1–99.3; Figure 2). Secondary analyses confirmed the findings using adjudication including serial measurements of hs-cTnT-Elecsys. Conclusions Hs-cTnI-EXL has comparable diagnostic performance to the currently best-validated hs-cTnT/I assays. Funding Acknowledgement Type of funding sources: Foundation. Main funding source(s): Swiss National Foundation, Swiss Heart Foundation
No takes yet. Share an insight, caveat, or question.
Koechlin et al. (2022) conducted an observational in Suspected myocardial infarction (n=1,454). hs-cTnI-EXL assay and 0/1h-algorithm vs. hs-cTnI-Architect and hs-cTnT-Elecsys assays was evaluated on Diagnostic accuracy for myocardial infarction quantified by the area under the receiver-operating-characteristic curve (AUC) at presentation (AUC 0.94, 95% CI 0.93-0.96). The hs-cTnI-EXL assay showed comparable diagnostic accuracy for MI to hs-cTnI-Architect and hs-cTnT-Elecsys, with 99.5% NPV using a 0/1h-algorithm.
Synapse has enriched 10 related papers. Consider them for comparative context: